Do you want to read an article? Please log in or register.
Early treatment initiation optimizes virologic and liver outcomes in pediatric patients with chronic hepatitis B aged 0-18 years
Hepatitis
Related content
Hepatitis
Type 2 Diabetes mellitus as an independent predictor of significant fibrosis in treatment-naïve chronic hepatitis B patients with concurrent hepatic steatosis
Hepatology
Li J, Xu L, Rui F, Tran S, Tsai PC, Tan Y, Toyoda H, Zeng QL, Trinh H, Hsu YC, Watanabe T, Abe H, Motoyama H, Yoshimaru Y, Suzuki T, Arai T, Atsukawa M, Vutien P, Marciano S, Bai X, Ni W, Geng N, Tseng CH, Liu J, Mi Y, Liu J, Ye Y, Zhu L, Chen RY, Zhu C, Maeda M, Liu JK, Henry L, Yeh ML, Huang CF, Huang JF, Dai CY, Gadano A, Cheung R, Chuang WL, Enomoto M, Tanaka Y, Aishima S, Yu ML, Wu C, Shi J, Nguyen MH
doi: 10.1097/HEP.0000000000001442
Further Publications
Five-Year Effectiveness and Renal Safety Following Switching to Tenofovir Alafenamide in Chronic Hepatitis B Patients With Renal Impairment
J Gastroenterol Hepatol
Ogawa E, Kohjima M, Koyanagi T, Dohmen K, Ooho A, Kawano A, Furusyo N, Kajiwara E, Satoh T, Takahashi K, Azuma K, Sugimoto R, Ichiki Y, Senju T, Amagase H, Tanaka M, Nakamuta M, Nomura H, Hayashi J, Kyushu University Liver Disease Study (KULDS) Group
doi: 10.1111/jgh.70059
Hepatitis
Long-term effectiveness of tenofovir alafenamide versus entecavir in treatment-naïve chronic hepatitis B: A REAL-B study
Am J Gastroenterol
Li J, Liu JK, Chau A, Linden S, Tsai PC, Nozaki A, Vutien P, Uojima H, Toyoda H, Honda T, Trinh H, Abe H, Ishikawa T, Atsukawa M, Watanabe T, Tsuji K, Huang DQ, Takaguchi K, Itobayashi E, Marciano S, Rui F, Ni W, Takahashi H, Chuang WL, Dai CY, Huang JF, Huang CF, Yeh ML, Zhu Y, Itokawa N, Kozuka R, Inoue K, Senoh T, Maeda M, Ito T, Morimoto M, Cheung R, Gadano A, Enomoto M, Tanaka Y, Lim SG, Wu C, Yu ML, Nguyen MH
doi: 10.14309/ajg.0000000000003881
Hepatitis
Service delivery models and care cascade outcomes for people living with chronic hepatitis B: a global systematic review and meta-analysis
Lancet Gastroenterol Hepatol
Stockdale AJ, Holt B, Bhadoria AS, Sadasivan A, Ikeda D, Pollack T, Ong JP, Pham T, Duong DB, Nguyen V, Ndow G, Chou R, Easterbrook P
doi: 10.1016/S2468-1253(25)00163-3
Hepatitis
EASL 2025 indications revisited: phase-specific outcomes with and without nucleos(t)ide analogue therapy in chronic hepatitis B virus infection
Gut
Tang S, Huang T, Tang R, Lin K, Luo C, Shen Y, Zhang K, Tang Y, Kong J, Chen Z, Fu J, Lin Q, Guo L, Wu Y, Li Y, Zhang J, Sun Z, You P, Zhang D, Chen Y, Lin X, Zhong C, Lin Z, Liu H, Huang Z, Zhou W, Dong P, Liu X, Zeng H, Qi X, Zeng Y
doi: 10.1136/gutjnl-2025-335449
RECOMMENDED
Hepatitis
AASLD/IDSA Practice Guideline on treatment of chronic hepatitis B
★ 3
Recommended by
Prof. Dr Stephan Vavricka, Faculty Member
Hepatology
Ghany MG, Pan CQ, Lok AS, Feld JJ, Lim JK, Wang SH, Kim AY, Tang AS, Nguyen MH, Naggie S, Sulkowski MS, Rodriguez-Baez N, Chen J, Murad MH, Mohammad KS, Terrault NA
doi: 10.1097/HEP.0000000000001549
Hepatitis
Single nucleotide polymorphisms in the bepirovirsen binding site have limited impact on treatment response in chronic hepatitis B
J Hepatol
Bouquet J, Speer SD, Koenig A, Livingston CM, Savarese M, Lau C, Angelini E, Galwey N, Yates P, Maynard L, You S, Cremer J, Paff M, Theodore D, Elston R, Walker J
doi: 10.1016/j.jhep.2025.12.025
Hepatology
Risk of hepatic and extrahepatic outcomes associated with metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction and alcohol-associated steatotic liver disease: a systematic review and meta-analysis
Lancet Gastroenterol Hepatol
Celsa C, Pennisi G, Tulone A, Ciancimino G, Vaccaro M, Pecorella F, Di Maria G, Enea M, Midiri F, Mantovani A, Targher G, Krag A, Rinella ME, Cammà C, Petta S
doi: 10.1016/S2468-1253(25)00188-8
Inflammatory Bowel Disease
Treatment sequences, outcomes, healthcare utilization, and costs in patients with inflammatory bowel diseases requiring advanced treatment-real world comparative effectiveness from German claims data
BMC Gastroenterol
Dignass A, Teich N, Kaiser S, Sünwoldt J, Dünweber C, Weinhold I, Borchert J, Kudernatsch R
doi: 10.1186/s12876-025-04022-7